Our work suggests that targeting a specific stem cell phenotype,
for example with immunotherapies, could be beneficial in patients with
oligodendroglioma.»
Using tumor models
for both astrocytoma and
oligodendroglioma, which are very similar to human tumors, they could show that one and the same cell type, called oligodendrocyte precursor cells, could give rise to both tumor forms.